All Stories

  1. Potential differences in receptor‐mediated G‐protein activation in postmortem human hippocampal membranes prepared from healthy controls and suicide victims
  2. Advancement in human neuroimaging based on proximity ligation assay in brain disease
  3. Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor–Receptor Interactions
  4. Long‐term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co‐administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus
  5. Detection, visualization and quantification of protein complexes in human Alzheimer’s disease brains using proximity ligation assay
  6. 5HT1AR-FGFR1 Heteroreceptor Complexes Differently Modulate GIRK Currents in the Dorsal Hippocampus and the Dorsal Raphe Serotonin Nucleus of Control Rats and of a Genetic Rat Model of Depression
  7. Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay
  8. GALR2 and Y1R agonists intranasal infusion enhanced adult ventral hippocampal neurogenesis and antidepressant‐like effects involving BDNF actions
  9. Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders
  10. Galanin and Neuropeptide Y Interaction Enhances Proliferation of Granule Precursor Cells and Expression of Neuroprotective Factors in the Rat Hippocampus with Consequent Augmented Spatial Memory
  11. Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats
  12. The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression
  13. Molecular Integration in Adenosine Heteroreceptor Complexes Through Allosteric and De-Phosphorylation (STEP) Mechanisms and its Role in Brain Disease
  14. The integrative role of G protein-coupled receptor heterocomplexes in Parkinson’s disease
  15. Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression
  16. Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression
  17. Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”
  18. The coming together of allosteric and phosphorylation mechanisms in the molecular integration of A2A heteroreceptor complexes in the dorsal and ventral striatal-pallidal GABA neurons
  19. Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases
  20. Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?
  21. The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders
  22. Amplification of potential thermogenetic mechanisms in cetacean brains compared to artiodactyl brains
  23. The Role of Central Serotonin Neurons and 5-HT Heteroreceptor Complexes in the Pathophysiology of Depression: A Historical Perspective and Future Prospects
  24. Molecular, biochemical and behavioural evidence for a novel oxytocin receptor and serotonin 2C receptor heterocomplex
  25. Galanin and neuropeptide Y interactions elicit antidepressant activity linked to neuronal precursor cells of the dentate gyrus in the ventral hippocampus
  26. Evidence for the existence of A2AR-TrkB heteroreceptor complexes in the dorsal hippocampus of the rat brain: Potential implications of A2AR and TrkB interplay upon ageing
  27. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson’s Disease and Schizophrenia
  28. Adenosine A2AReceptors in Substance Use Disorders: A Focus on Cocaine
  29. Existence of FGFR1-5-HT1AR heteroreceptor complexes in hippocampal astrocytes. Putative link to 5-HT and FGF2 modulation of hippocampal gamma oscillations
  30. Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia
  31. Acute cocaine treatment enhances the antagonistic allosteric adenosine A2A-dopamine D2 receptor–receptor interactions in rat dorsal striatum without increasing significantly extracellular dopamine levels
  32. A2AR Transmembrane 2 Peptide Administration Disrupts the A2AR-A2AR Homoreceptor but Not the A2AR-D2R Heteroreceptor Complex: Lack of Actions on Rodent Cocaine Self-Administration
  33. OSU-6162, a Sigma1R Ligand in Low Doses, Can Further Increase the Effects of Cocaine Self-Administration on Accumbal D2R Heteroreceptor Complexes
  34. Differential allosteric modulation within dopamine D2R - neurotensin NTS1R and D2R - serotonin 5-HT2AR receptor complexes gives bias to intracellular calcium signalling
  35. Desipramine restores the alterations in circadian entrainment induced by prenatal exposure to glucocorticoids
  36. Increased Ethanol Consumption and Locomotion Develop upon Ethanol Deprivation in Rats Overexpressing the Adenosine (A)2A Receptor
  37. Oligomeric Receptor Complexes and Their Allosteric Receptor-Receptor Interactions in the Plasma Membrane Represent a New Biological Principle for Integration of Signals in the CNS
  38. Can Allosteric Receptor-Protein Interactions in Receptor Complexes Be a Molecular Mechanism Involved in Cancer Immune Therapy?
  39. Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
  40. Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D2 Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
  41. On the G Protein-Coupled Receptor Neuromodulation of the Claustrum
  42. Acute Cocaine Enhances Dopamine D2R Recognition and Signaling and Counteracts D2R Internalization in Sigma1R-D2R Heteroreceptor Complexes
  43. A2AR-D2R Heteroreceptor Complexes in Cocaine Reward and Addiction
  44. Brain of the tree pangolin (Manis tricuspis ). III. The unusual locus coeruleus complex
  45. Glutamate heteroreceptor complexes in the brain
  46. Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer
  47. Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors
  48. Dopamine receptor supersensitivity
  49. Receptor–Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment
  50. Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington’s disease
  51. Transcriptomic integration of D4R and MOR signaling in the rat caudate putamen
  52. A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats
  53. Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
  54. Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors
  55. Disruption of A2AR-D2R Heteroreceptor Complexes After A2AR Transmembrane 5 Peptide Administration Enhances Cocaine Self-Administration in Rats
  56. Effects of Long-Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats
  57. Differential activation of arginine-vasopressin receptor subtypes in the amygdaloid modulation of anxiety in the rat by arginine-vasopressin
  58. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia
  59. Central administration of galanin N-terminal fragment 1-15 decreases the voluntary alcohol intake in rats
  60. Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum
  61. Disturbances in the FGFR1-5-HT1A Heteroreceptor Complexes in the Raphe-Hippocampal 5-HT System Develop in a Genetic Rat Model of Depression
  62. Existence of Brain 5-HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5-HT1A Receptor Recognition
  63. Cocaine self-administration specifically increases A2AR-D2R and D2R-sigma1R heteroreceptor complexes in the rat nucleus accumbens shell. Relevance for cocaine use disorder
  64. Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
  65. Dopamine D1 receptor activity is involved in the increased anxiety levels observed in STZ-induced diabetes in rats
  66. Characterization of the interaction between the dopamine D4 receptor, KLHL12 and β-arrestins
  67. Telocytes in their context with other intercellular communication agents
  68. Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission
  69. Dopamine D4receptor stimulation prevents nigrostriatal dopamine pathway activation by morphine: relevance for drug addiction
  70. Cocaine self-administration differentially affects allosteric A2A-D2 receptor-receptor interactions in the striatum. Relevance for cocaine use disorder
  71. Purinergic signaling in Parkinson's disease. Relevance for treatment
  72. Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia
  73. The fast-off hypothesis revisited: A functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor
  74. Galanin (1–15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system
  75. Neurotensin: A role in substance use disorder?
  76. Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes
  77. The multi-facet aspects of cell sentience and their relevance for the integrative brain actions: role of membrane protein energy landscape
  78. Co-immunoprecipitation from Brain
  79. FGFR1–5-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression
  80. In Situ Proximity Ligation Assay to Study and Understand the Distribution and Balance of GPCR Homo- and Heteroreceptor Complexes in the Brain
  81. Role of D 2 -like Heteroreceptor Complexes in the Effects of Cocaine, Morphine, and Hallucinogens
  82. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects
  83. Heteroreceptor Complexes and their Allosteric Receptor–Receptor Interactions as a Novel Biological Principle for Integration of Communication in the CNS: Targets for Drug Development
  84. The zinc binding receptor GPR39 interacts with 5-HT1A and GalR1 to form dynamic heteroreceptor complexes with signaling diversity
  85. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2Areceptors
  86. Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5
  87. The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes
  88. Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression
  89. The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural–glial networks
  90. Corrigendum to “Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles” [Physiol. Behav. 142 (2015) 79–84]
  91. Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets
  92. Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles
  93. A Role for Galanin N-Terminal Fragment (1–15) in Anxiety- and Depression-Related Behaviors in Rats
  94. On the role of the extracellular space on the holistic behavior of the brain
  95. Evidence for the existence of FGFR1–5-HT1A heteroreceptor complexes in the midbrain raphe 5-HT system
  96. Classic and Modern Meridian Studies: A Review of Low Hydraulic Resistance Channels along Meridians and Their Relevance for Therapeutic Effects in Traditional Chinese Medicine
  97. Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease
  98. On the role of A2A and D2 receptors in control of cocaine and food-seeking behaviors in rats
  99. G-protein-coupled receptor type A heteromers as an emerging therapeutic target
  100. Nuclear organization of cholinergic, catecholaminergic, serotonergic and orexinergic systems in the brain of the Tasmanian devil (Sarcophilus harrisii)
  101. Potential of caveolae in the therapy of cardiovascular and neurological diseases
  102. Preferential activation by galanin 1–15 fragment of the GalR1 protomer of a GalR1–GalR2 heteroreceptor complex
  103. Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networks
  104. Dopamine D1 and D2 receptor immunoreactivities in the arcuate-median eminence complex and their link to the tubero-infundibular dopamine neurons
  105. On the role of adenosine (A)2A receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats
  106. In Vitro Effects of Cocaine on Tunneling Nanotube Formation and Extracellular Vesicle Release in Glioblastoma Cell Cultures
  107. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex
  108. The impact of receptor–receptor interactions in heteroreceptor complexes on brain plasticity
  109. Adenosine (A)2A receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach
  110. Information handling by the brain: proposal of a new “paradigm” involving the roamer type of volume transmission and the tunneling nanotube type of wiring transmission
  111. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions
  112. The G Protein-Coupled Receptor Heterodimer Network (GPCR-HetNet) and Its Hub Components
  113. Diversity and Bias through Receptor–Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization
  114. Dopamine D4 Receptor Counteracts Morphine-Induced Changes in µ Opioid Receptor Signaling in the Striosomes of the Rat Caudate Putamen
  115. Life without glutamate: the epigenetic effects of glutamate deletion
  116. Dopamine D2 heteroreceptor complexes and their receptor–receptor interactions in ventral striatum
  117. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes
  118. Volume Transmission and the Russian-Doll Organization of Brain Cell Networks
  119. Understanding the balance and integration of volume and synaptic transmission. Relevance for psychiatry
  120. Neuroglobin as a regulator of mitochondrial-dependent apoptosis: A bioinformatics analysis
  121. Dynamic modulation of FGFR1–5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2
  122. Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor
  123. Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field
  124. Early modulation by the dopamine D4receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen
  125. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers
  126. Volume transmission and its different forms in the central nervous system
  127. A New Interpretative Paradigm for Conformational Protein Diseases
  128. Integrin triplets of marine sponges in the murine and human MHCI-CD8 interface and in the interface of human neural receptor heteromers and subunits
  129. The Vigilance Promoting Drug Modafinil Modulates Serotonin Transmission in the Rat Prefrontal Cortex and Dorsal Raphe Nucleus. Possible Relevance for Its Postulated Antidepressant Activity
  130. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellularGABAlevels in the rat striatumin vivo
  131. Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats
  132. Bioluminescence Resonance Energy Transfer Methods to Study G Protein-Coupled Receptor–Receptor Tyrosine Kinase Heteroreceptor Complexes
  133. G Protein–Coupled Receptor Heterodimerization in the Brain
  134. On the G-Protein-Coupled Receptor Heteromers and Their Allosteric Receptor-Receptor Interactions in the Central Nervous System: Focus on Their Role in Pain Modulation
  135. Architectural Organization of the African Elephant Diencephalon and Brainstem
  136. The Neurobiology of Imagination: Possible Role of Interaction-Dominant Dynamics and Default Mode Network
  137. Intercalated and paracapsular cell islands of the adult rat amygdala: A combined rapid-Golgi, ultrastructural, and immunohistochemical account
  138. Voltage sensitivities and deactivation kinetics of histamine H3 and H4 receptors
  139. Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system
  140. G protein-coupled receptor oligomerization and brain integration: Focus on adenosinergic transmission
  141. On the role of volume transmission and receptor–receptor interactions in social behaviour: Focus on central catecholamine and oxytocin neurons
  142. Possible genetic and epigenetic links between human inner speech, schizophrenia and altruism
  143. A2A/D2 receptor heteromerization in a model of Parkinson's disease. Focus on striatal aminoacidergic signaling
  144. Brain integration: From networks to the cellular–molecular level
  145. Neuronal correlates to consciousness. The “Hall of Mirrors” metaphor describing consciousness as an epiphenomenon of multiple dynamic mosaics of cortical functional modules
  146. The intercalated paracapsular islands as a module for integration of signals regulating anxiety in the amygdala
  147. Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R
  148. Fluorescence resonance energy transfer-based technologies in the study of protein–protein interactions at the cell surface
  149. Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor–receptor interactions
  150. Organization and number of orexinergic neurons in the hypothalamus of two species of Cetartiodactyla: A comparison of giraffe (Giraffa camelopardalis) and harbour porpoise (Phocoena phocoena)
  151. Integrin triplets of marine sponges in human D2 receptor heteromers
  152. Aspects on the integrative actions of the brain from neural networks to “brain-body medicine”
  153. Integrin Triplets of Marine Sponges in Human Brain Receptor Heteromers
  154. The Existence of FGFR1-5-HT1A Receptor Heterocomplexes in Midbrain 5-HT Neurons of the Rat: Relevance for Neuroplasticity
  155. Nuclear organization of cholinergic, putative catecholaminergic, serotonergic and orexinergic systems in the brain of the African pygmy mouse (Mus minutoides): Organizational complexity is preserved in small brains
  156. Effects of cocaine self-administration and extinction on D2-like and A2Areceptor recognition and D2-like/Giprotein coupling in rat striatum
  157. A Novel Mechanism of Cocaine to Enhance Dopamine D2-Like Receptor Mediated Neurochemical and Behavioral Effects. An In Vivo and In Vitro Study
  158. Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures
  159. The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
  160. Extrasynaptic Neurotransmission as a Way of Modulating Neuronal Functions
  161. Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
  162. Extrasynaptic Neurotransmission in the Modulation of Brain Function. Focus on the Striatal Neuronal–Glial Networks
  163. Fibroblast Growth Factor Receptor 1– 5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity
  164. On the existence and function of galanin receptor heteromers in the central nervous system
  165. Distribution of dopamine D2-like receptors in the rat amygdala and their role in the modulation of unconditioned fear and anxiety
  166. Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release - a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat
  167. Central Nervous System and Computation
  168. Increased affinity of dopamine for D2-like versus D1-like receptors. Relevance for volume transmission in interpreting PET findings
  169. On the origin of the triplet puzzle of homologies in receptor heteromers: toll-like receptor triplets in different types of receptors
  170. Agonist-specific voltage sensitivity at the dopamine D2S receptor – Molecular determinants and relevance to therapeutic ligands
  171. On the Origin of the Triplet Puzzle of Homologies in Receptor Heteromers: Immunoglobulin Triplets in Different Types of Receptors
  172. Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms
  173. Differential expression of muscarinic acetylcholine receptor subtypes in Jurkat cells and their signaling
  174. Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation
  175. Galanin receptor/Neuropeptide Y receptor interactions in the dorsal raphe nucleus of the rat
  176. Moonlighting characteristics of G protein-coupled receptors: Focus on receptor heteromers and relevance for neurodegeneration
  177. Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: An in vivo microdialysis study
  178. Agonist-induced formation of FGFR1 homodimers and signaling differ among members of the FGF family
  179. Adenosine receptor containing oligomers: Their role in the control of dopamine and glutamate neurotransmission in the brain
  180. Bioinformatics and mathematical modelling in the study of receptor–receptor interactions and receptor oligomerization
  181. The Triplet Puzzle of Homologies in Receptor Heteromers Exists Also in Other Types of Protein–Protein Interactions
  182. Dopamine D4 receptor oligomerization - contribution to receptor biogenesis
  183. On the Existence of a Possible A2A–D2–β-Arrestin2 Complex: A2A Agonist Modulation of D2 Agonist-Induced β-Arrestin2 Recruitment
  184. Distribution of orexin-A immunoreactive neurons and their terminal networks in the brain of the rock hyrax, Procavia capensis
  185. Muscarinic receptor family interacting proteins: Role in receptor function
  186. Dissecting the Conserved NPxxY Motif of the M3 Muscarinic Acetylcholine Receptor: Critical Role of Asp-7.49 for Receptor Signaling and Multiprotein Complex Formation
  187. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor–receptor interactions
  188. A Window into the Heterogeneity of Human Cerebrospinal Fluid AβPeptides
  189. Distribution of orexinergic neurons and their terminal networks in the brains of two species of African mole rats
  190. G-protein-coupled receptor heteromer dynamics
  191. Characterization of the A2AR–D2R interface: Focus on the role of the C-terminal tail and the transmembrane helices
  192. Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice
  193. Direct involvement of σ-1 receptors in the dopamine D 1 receptor-mediated effects of cocaine
  194. Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble into functionally interacting heteromers
  195. FGF-2/FGFR1 neurotrophic system expression level and its basal activation do not account for the age-dependent decline of precursor cell proliferation in the subventricular zone of rat brain
  196. International Workshop at the Nobel Forum, Karolinska Institutet on G protein-coupled receptors: finding the words to describe monomers, oligomers, and their molecular mechanisms and defining their meaning. Can a consensus be reached?
  197. Editorial
  198. Understanding wiring and volume transmission
  199. G protein-coupled receptor oligomerization for what?
  200. GABAA ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety
  201. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor–receptor interactions
  202. The Galanin N-terminal fragment (1–15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype
  203. The M5 muscarinic acetylcholine receptor third intracellular loop regulates receptor function and oligomerization
  204. An integrated view on the role of receptor mosaics at perisynaptic level: focus on adenosine A2A, dopamine D2, cannabinoid CB1, and metabotropic glutamate mGlu5receptors
  205. Adenosine-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
  206. Nuclear organization of cholinergic, putative catecholaminergic and serotonergic nuclei in the brain of the eastern rock elephant shrew, Elephantulus myurus
  207. Organization of cholinergic, putative catecholaminergic and serotonergic nuclei in the diencephalon, mibrain and pons of sub-adult male giraffes
  208. On the expanding terminology in the GPCR field: The meaning of receptor mosaics and receptor heteromers
  209. On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson’s disease: studies with the P2X7 receptor antagonist A-438079
  210. Cocaine produces D2R-mediated conformational changes in the adenosine A2AR-dopamine D2R heteromer
  211. Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine
  212. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R
  213. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization
  214. Differential Sensitivity of A2A and Especially D2 Receptor Trafficking to Cocaine Compared with Lipid Rafts in Cotransfected CHO Cell Lines. Novel Actions of Cocaine Independent of the DA Transporter
  215. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis
  216. Receptor–receptor interactions: A novel concept in brain integration
  217. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis
  218. The discovery of central monoamine neurons gave volume transmission to the wired brain
  219. Impaired M3 Muscarinic Acetylcholine Receptor Signal Transduction Through Blockade of Binding of Multiple Proteins to its Third Intracellular Loop
  220. Neurochemical Modulation of Central Cardiovascular Control: The Integrative Role of Galanin
  221. Homocysteine Potentiates Seizures and Cell Loss Induced by Pilocarpine Treatment
  222. Triplet Puzzle: Homologies of Receptor Heteromers
  223. Theoretical Considerations on the Topological Organization of Receptor Mosaics
  224. Emerging Evidence for Neurotensin Receptor 1 Antagonists as Novel Pharmaceutics in Neurodegenerative Disorders
  225. Nuclear organization and morphology of cholinergic, putative catecholaminergic and serotonergic neurons in the brain of the rock hyrax, Procavia capensis
  226. Interactions between Calmodulin, Adenosine A2A, and Dopamine D2Receptors
  227. Preface
  228. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain
  229. Protection of the Neostriatal Dopamine Stores against Reserpine by Local Treatment with Metatyramine
  230. Identification of Sympathetic Cholinergic Nerve Terminals in Arterioles of Skeletal Muscle
  231. Studies on Uptake Mechanisms in Central Monoamine Neurones
  232. Functional Role of the Nigro-Neostriatal Dopamine Neurons*)
  233. Failure of Reserpine to Deplete Noradrenaline Neurons of α-Methylnoradrenaline Formed from α-Methyl DOPA
  234. Site of Action of Reserpine
  235. Building a new conceptual framework for receptor heteromers
  236. Brain Receptor Mosaics and Their Intramembrane Receptor-Receptor Interactions: Molecular Integration in Transmission and Novel Targets for Drug Development
  237. Possible role of receptor heteromers in multiple sclerosis
  238. Implications of the ‘Energide’ concept for communication and information handling in the central nervous system
  239. Cannabinoid CB1 and Cholecystokinin CCK2 Receptors Modulate, in an Opposing Way, Electrically Evoked [3H]GABA Efflux from Rat Cerebral Cortex Cell Cultures: Possible Relevance for Cortical GABA Transmission and Anxiety
  240. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia
  241. Cell–Cell Communication Through the Extracellular Space
  242. The Nigro-Striatal DA Neurons and Mechanisms of Their Degeneration in Parkinson’s Disease
  243. Fibroblast growth factor-2 and its receptor expression in proliferating precursor cells of the subventricular zone in the adult rat brain
  244. Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors
  245. Voltage-sensitivity at the human dopamine D2S receptor is agonist-specific
  246. Common key-signals in learning and neurodegeneration: focus on excito-amino acids, β-amyloid peptides and α-synuclein
  247. Differential voltage-sensitivity of D2-like dopamine receptors
  248. Electrophysiology-based analysis of human histamine H4 receptor pharmacology using GIRK channel coupling in Xenopus oocytes
  249. Nuclear organization and morphology of cholinergic, putative catecholaminergic and serotonergic neurons in the brain of the Cape porcupine (Hystrix africaeaustralis): Increased brain size does not lead to increased organizational complexity
  250. How Calmodulin Interacts with the Adenosine A2Aand the Dopamine D2Receptors
  251. A new road to neuroinflammation in Parkinson's disease?
  252. Cellular localization and distribution of dopamine D4 receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks
  253. Neurotensin receptors as modulators of glutamatergic transmission
  254. Receptor mosaics of neural and immune communication: Possible implications for basal ganglia functions
  255. Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology
  256. Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains
  257. The basal ganglia—from neuronal systems to molecular networks
  258. Understanding neuronal molecular networks builds on neuronal cellular network architecture
  259. Identification of Dopamine D1–D3Receptor Heteromers
  260. Nuclear organization and morphology of cholinergic, putative catecholaminergic and serotonergic neurons in the brains of two species of African mole-rat
  261. Detection of heteromerization of more than two proteins by sequential BRET-FRET
  262. On the key role played by altered protein conformation in Parkinson’s disease
  263. Opposite patterns of age-associated changes in neurons and glial cells of the thalamus of human brain
  264. Time-course of immediate early gene expression in hippocampal subregions of adrenalectomized rats after acute corticosterone challenge
  265. Wiring and Volume Transmission in Rat Amygdala. Implications for Fear and Anxiety
  266. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
  267. The novel cyclooxygenase-2 inhibitor GW637185X protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
  268. Nicotine-induced fibroblast growth factor-2 restores the age-related decline of precursor cell proliferation in the subventricular zone of rat brain
  269. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain
  270. Distribution and morphology of putative catecholaminergic and serotonergic neurons in the brain of the greater canerat, Thryonomys swinderianus
  271. Nuclear organization and morphology of serotonergic neurons in the brain of the Nile crocodile, Crocodylus niloticus
  272. Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol
  273. Voltage-dependence of the human dopamine D2 receptor
  274. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release
  275. Neurotensin Receptor Involvement in the Rise of Extracellular Glutamate Levels and Apoptotic Nerve Cell Death in Primary Cortical Cultures after Oxygen and Glucose Deprivation
  276. Distribution and morphology of catecholaminergic and serotonergic neurons in the brain of the highveld gerbil, Tatera brantsii
  277. Distribution and morphology of putative catecholaminergic and serotonergic neurons in the medulla oblongata of a sub-adult giraffe, Giraffa camelopardalis
  278. Adenosine A2Areceptors, dopamine D2receptors and their interactions in Parkinson's disease
  279. Role of Cooperativity in Protein Folding and Protein Mosaic Assemblage Relevance for Protein Conformational Diseases
  280. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain
  281. Adenosine receptor–dopamine receptor interactions in the basal ganglia and their relevance for brain function
  282. Neurotransmitter receptor heteromers and their integrative role in ‘local modules’: The striatal spine module
  283. Does the human brain have unique genetically determined networks coding logical and ethical principles and aesthetics? From Plato to novel mirror networks
  284. From the Golgi–Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission
  285. Intercellular communication in the brain
  286. Mesolimbic dopamine and cortico-accumbens glutamate afferents as major targets for the regulation of the ventral striato-pallidal GABA pathways by neurotensin peptides
  287. Observations on the giraffe central nervous system related to the corticospinal tract, motor cortex and spinal cord: What difference does a long neck make?
  288. On the role of receptor–receptor interactions and volume transmission in learning and memory
  289. One century of progress in neuroscience founded on Golgi and Cajal's outstanding experimental and theoretical contributions
  290. Hyper-Homocysteinemia Alters Amyloid Peptide-Clusterin Interactions and Neuroglial Network Morphology and Function in the Caudate After Intrastriatal Injection of Amyloid Peptides
  291. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes
  292. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal
  293. Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation
  294. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y1 receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression
  295. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption
  296. Adenosine Receptor Heteromers and their Integrative Role in Striatal Function
  297. Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain
  298. Dopamine D4 receptor activation decreases the expression of μ-opioid receptors in the rat striatum
  299. Possible Relevance of Receptor-Receptor Interactions between Viral- and Host-Coded Receptors for Viral-Induced Disease
  300. Choline acetyltransferase immunoreactive cortical interneurons do not occur in all rodents: A study of the phylogenetic occurrence of this neural characteristic
  301. Allosteric Modulation of Dopamine D2Receptors by Homocysteine
  302. Targeting adenosine A2A receptors in Parkinson's disease
  303. Intramembrane receptor–receptor interactions: a novel principle in molecular medicine
  304. Receptor–receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins
  305. The Concept of Protein Mosaics: Physiological Role and Relevance for Prion Disease
  306. Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias
  307. Receptor–receptor interactions in central cardiovascular regulation. Focus on neuropeptide/α2-adrenoreceptor interactions in the nucleus tractus solitarius
  308. Receptor–receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia
  309. Aβ peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer’s disease
  310. A boolean network modelling of receptor mosaics relevance of topology and cooperativity
  311. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms
  312. The brain as a system of nested but partially overlapping networks. Heuristic relevance of the model for brain physiology and pathology
  313. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens
  314. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y1receptor subtype
  315. Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function
  316. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety
  317. Volume transmission and wiring transmission from cellular to molecular networks: history and perspectives
  318. Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine
  319. The Two-State Dimer Receptor Model: A General Model for Receptor Dimers
  320. On the Existence of a Global Molecular Network Enmeshing the Whole Central Nervous System: Physiological and Pathological Implications
  321. Corticosterone Actions on the Hippocampal Brain-Derived Neurotrophic Factor Expression are Mediated by Exon IV Promoter
  322. Nuclear parcellation of certain immunohistochemically identifiable neuronal systems in the midbrain and pons of the Highveld molerat (Cryptomys hottentotus)
  323. The distribution of dopamine D1 receptor and μ-opioid receptor 1 receptor immunoreactivities in the amygdala and interstitial nucleus of the posterior limb of the anterior commissure: Relationships to tyrosine hydroxylase and opioid peptide terminal sy...
  324. Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: Relevance for volume transmission
  325. New Methods to Evaluate Colocalization of Fluorophores in Immunocytochemical Preparations as Exemplified by a Study on A2Aand D2Receptors in Chinese Hamster Ovary Cells
  326. Dimer-based model for heptaspanning membrane receptors
  327. Oxytocin increases the density of high affinity α2-adrenoceptors within the hypothalamus, the amygdala and the nucleus of the solitary tract in ovariectomized rats
  328. Erratum to “Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors”
  329. Role of galanin and galanin(1–15) on central cardiovascular control
  330. How receptor mosaics decode transmitter signals. Possible relevance of cooperativity
  331. Detection of β-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain
  332. Intracisternal galanin/angiotensin II interactions in central cardiovascular control
  333. Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat
  334. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors
  335. Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP
  336. Adenosine A2A and Dopamine D2 Heteromeric Receptor Complexes and Their Function
  337. Computer-Assisted Image Analysis of Caveolin-1 Involvement in the Internalization Process of Adenosine A2A–Dopamine D2 Receptor Heterodimers
  338. How Proteins Come Together in the Plasma Membrane and Function in Macromolecular Assemblies: Focus on Receptor Mosaics
  339. Molecular mechanisms involved in the adenosine A1 and A2A receptor-induced neuronal differentiation in neuroblastoma cells and striatal primary cultures
  340. Partners for Adenosine A1 Receptors
  341. Receptor–Receptor Interactions, Receptor Mosaics, and Basic Principles of Molecular Network Organization: Possible Implications for Drug Development
  342. Role of Electrostatic Interaction in Receptor–Receptor Heteromerization
  343. Concluding Remarks
  344. Effects of sarizotan on the corticostriatal glutamate pathways
  345. Introductory Remarks
  346. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: A dual probe microdialysis study in awake rat
  347. Subchronic haloperidol increases CB1 receptor binding and G protein coupling in discrete regions of the basal ganglia
  348. Trafficking of Adenosine A2A and Dopamine D2 Receptors
  349. Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortex
  350. Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes
  351. Motor response to amphetamine treatment, task-specific training, and limited motor experience in a postacute animal stroke model
  352. Nicotine-induced FGF-2 mRNA in rat brain is preserved during aging
  353. Combining Mass Spectrometry and Pull-Down Techniques for the Study of Receptor Heteromerization. Direct Epitope−Epitope Electrostatic Interactions between Adenosine A2Aand Dopamine D2Receptors
  354. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson’s disease
  355. On the Molecular Basis of the Receptor Mosaic Hypothesis of the Engram
  356. Neuronal A1 receptors mediate increase in extracellular kynurenic acid after local intrastriatal adenosine infusion
  357. Energy gradients for the homeostatic control of brain ECF composition and for VT signal migration: introduction of the tide hypothesis
  358. Adenosine A2A-dopamine D2 receptor–receptor heteromers. Targets for neuro-psychiatric disorders
  359. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease
  360. Introduction
  361. Striatal plasticity and motor learning—importance of circadian rhythms, sleep stages and dreaming…
  362. Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2
  363. Corticosterone strongly increases the affinity of dorsal raphe 5-HT1A receptors
  364. Studies on homocysteine plasma levels in Alzheimer?s patients. Relevance for neurodegeneration
  365. Neurotensin Enhances Endogenous Extracellular Glutamate Levels in Primary Cultures of Rat Cortical Neurons: Involvement of Neurotensin Receptor in NMDA Induced Excitotoxicity
  366. Long-Term Modulation By Postnatal Oxytocin of the alpha2-Adrenoceptor Agonist Binding Sites in Central Autonomic Regions and the Role of Prenatal Stress
  367. Acute intermittent nicotine treatment produces a reduction in the total number of FGF-2 immunoreactive astroglial cells in the substantia nigra of the rat: a stereological analysis
  368. Biochemical Identification of the Dopamine D2 Receptor Domains Interacting With the Adenosine A2A Receptor
  369. Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer’s disease patients and in Parkinson’s disease patients
  370. The Distribution and Morphological Characteristics of Catecholaminergic Cells in the Diencephalon and Midbrain of the Bottlenose Dolphin (Tursiops truncatus)
  371. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
  372. Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatum
  373. Angiotensin II modulates the cardiovascular responses to microinjection of NPY Y1 and NPY Y2 receptor agonists into the nucleus tractus solitarii of the rat
  374. Adenosine A2A-Dopamine D2Receptor-Receptor Heteromerization
  375. Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons
  376. Determination of histamine in microdialysis samples from rat brain by microbore column liquid chromatography following intramolecular excimer-forming derivatization with pyrene-labeling reagent
  377. The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation
  378. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering
  379. Antagonistic Oxytocin/α2-Adrenoreceptor Interactions in the Nucleus Tractus Solitarii: Relevance for Central Cardiovascular Control
  380. Involvement of Adenosine A1 and A2A Receptors in the Motor Effects of Caffeine after its Acute and Chronic Administration
  381. Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture
  382. Interactions among adenosine deaminase, adenosine A1 receptors and dopamine D1 receptors in stably cotransfected fibroblast cells and neurons
  383. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function
  384. Propranolol blocks the tachycardia induced by galanin (1–15) but not by galanin (1–29)
  385. Reversible and irreversible components of [3H]-N-propylnorapomorphine interaction with rat striatal membranes
  386. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A2A and dopamine D2 receptors
  387. Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: Possible relevance for wakefulness and depression
  388. Quantitative dual-probe microdialysis: evaluation of [3H]mannitol diffusion in agar and rat striatum
  389. Quantitative dual-probe microdialysis: mathematical model
and analysis
  390. Theory relating in vitro and in vivo microdialysis with one or two probes
  391. Coaggregation, Cointernalization, and Codesensitization of Adenosine A2AReceptors and Dopamine D2Receptors
  392. Biphasic Autoregulation of Mineralocorticoid Receptor mRNA in the Medial Septal Nucleus by Aldosterone
  393. Increased density of galanin binding sites in the dorsal raphe in a genetic rat model of depression
  394. Activation of Adensine A1 and A2A Receptors Modulates Dopamine D2 Receptor-Induced Responses in Stably Transfected Human Neuroblastoma Cells
  395. The Selective mGlu5 Receptor Agonist CHPG Inhibits Quinpirole-Induced Turning in 6-Hydroxydopamine-Lesioned Rats and Modulates the Binding Characteristics of Dopamine D2 Receptors in the Rat Striatum Interactions with Adenosine A2a Receptors
  396. Central galanin and N-terminal galanin fragment induce c-Fos immunoreactivity in the medulla oblongata of the anesthetized rat
  397. Relationships of 5-hydroxytryptamine immunoreactive terminal-like varicosities to 5-hydroxytryptamine-2A receptor-immunoreactive neuronal processes in the rat forebrain
  398. Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates
  399. Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease
  400. D2 dopamine receptor-G protein coupling. Cross-regulation of agonist and guanosine nucleotide binding sites
  401. Erratum to “Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine1A receptor mediated function in the rat” [Neurosci. Lett. 299 (2001) 145–149]
  402. Voltage-operated Ca2+ channels involved in K+-evoked release of vasoactive intestinal polypeptide from the rat hypothalamus
  403. Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs
  404. Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine1A receptor mediated function in the rat
  405. Adenosine/dopamine receptor-receptor interactions in the central nervous system
  406. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain
  407. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum
  408. Systemic oxytocin treatment modulates α2-adrenoceptors in telencephalic and diencephalic regions of the rat
  409. Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2Areceptors in dopamine D2receptor regulation in the rat dopamine-denervated striatum
  410. Evidence for Adenosine/Dopamine Receptor Interactions Indications for Heteromerization
  411. Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil
  412. Central nicotinic receptors, neurotrophic factors and neuroprotection
  413. Gluco- and mineralocorticoid receptor-mediated regulation of neurotrophic factor gene expression in the dorsal hippocampus and the neocortex of the rat
  414. Dopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
  415. Fetal Ventral Mesencephalic Grafts Functionally Reduce the Dopamine D2 Receptor Supersensitivity in Partially Dopamine Reinnervated Host Striatum
  416. Galanin/alpha2-receptor interactions in central cardiovascular control
  417. Intracerebral infusion of3H-dopamine and3H-mannitol in the striatum of halothane-anaesthetized male rats.A dual-probe microdialysis study of long-distance diffusion
  418. The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1–15)
  419. Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats
  420. Ontogeny of the motor inhibitory role of dopamine D3 receptor subtype in rats
  421. Modulation of [35S]GTPγS binding to Chinese hamster ovary cell membranes by D2(short) dopamine receptors
  422. Adenosine as a volume transmission signal. A feedback detector of neuronal activation
  423. Diffusion of radiolabeled dopamine, its metabolites and mannitol in the rat striatum studied by dual-probe microdialysis
  424. Evidence for the existence of pulses of dopamine in the extracellular space of the rat striatum
  425. Internalization of Intracerebrally Administered Porcine Galanin (1–29) by a Discrete Nerve Cell Population in the Hippocampus of the Rat
  426. Long distance signalling in volume transmission. Focus on clearance mechanisms
  427. Neurotensin increases endogenous glutamate release in rat cortical slices
  428. Opening address
  429. Phorbol ester induced changes in tight and adherens junctions in the choroid plexus epithelium and in the ependyma
  430. Restoration of dopamine transmission in graft reinnervated striatum. Evidence for regulation of dopamine D2 receptor function in regions lacking dopamine
  431. Volume transmission as a key feature of information handling in the central nervous system possible new interpretative value of the Turing's B-type machine
  432. The nicotinic acetylcholine receptor agonist (±)-epibatidine increases FGF-2 mRNA and protein levels in the rat brain
  433. Stimulation of adenosine A1receptors attenuates dopamine D1receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1receptor-mediated turning behaviour
  434. A stereological study on the neuroprotective actions of acute Modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse
  435. The autonomic nervous system and the histochemical fluorescence method for the microscopical localization of catecholamines and serotonin
  436. Subchronic toluene exposure in low concentrations produces signs of reduced dysfunction in the 6-hydroxydopamine lesioned nigrostriatal dopaminergic system of the rat
  437. Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors
  438. Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat
  439. Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression
  440. The Vigilance Promoting Drug Modafinil Increases Extracellular Glutamate Levels in the Medial Preoptic Area and the Posterior Hypothalamus of the Conscious Rat Prevention by Local GABAA Receptor Blockade
  441. Volume transmission in the CNS and its relevance for neuropsychopharmacology
  442. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus
  443. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat
  444. In Vitro Evidence for Increased Facilitation of Striatal Acetylcholine Release via Pre- and Postsynaptic NMDA Receptotors in Hemiparkinsonian Rats
  445. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum
  446. Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus
  447. Pharmacological characterization of dopamine-stimulated [35S]-Guanosine 5′-(γ-thiotriphosphate) ([35S]GTPγS) binding in rat striatal membranes
  448. Galanin and NH2-Terminal Galanin Fragments in Central Cardiovascular Regulation a
  449. Galanin Modulates 5-Hydroxytryptamine Functions: Focus on Galanin and Galanin Fragment/5-Hydroxytryptamine1A Receptor Interactions in the Braina
  450. Modulation of a 5-HT1A Receptor-Mediated Behavioral Response by the Neuropeptide Galanin
  451. Review Article Reciprocaldopamine-glutamatemodulation of release in the basalganglia
  452. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission
  453. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment
  454. Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats
  455. Age-related alteration of the adenosine/dopamine balance in the rat striatum
  456. On the relationship of neuropeptide Y Y1 receptor-immunoreactive neuronal structures to the neuropeptide Y-immunoreactive nerve terminal networks. A double immunolabelling analysis in the rat brain
  457. Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia1Published on the World Wide Web on 12 Januar...
  458. Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain
  459. The emergence of the volume transmission concept1Published on the World Wide Web on 12 January 1998.1
  460. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats
  461. Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat
  462. Adenosine A1Receptor-mediated Modulation of Dopamine D1Receptors in Stably Cotransfected Fibroblast Cells
  463. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
  464. Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat
  465. Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats
  466. Modafinil: An antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers
  467. Modulation of [3H]quinpirole binding to dopaminergic receptors by adenosine A2A receptors
  468. Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
  469. Differential Effects of lntrastriatal Neurotensin(1-13) and Neurotensin(8-13) on Striatal Dopamine and Pallidal GABA Release. A Dual-probe Microdialysis Study in the Awake Rat
  470. Localization of angiotensin II AT1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata
  471. On the role of c-fos expression in striatal transmission. The antisense oligonucleotide approach
  472. Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic
  473. Prolonged treatment with haloperidol and clozapine in the rat: differential effects on spontaneous and theophylline-induced motor activity
  474. Chronic Nicotine Treatment Differentially Regulates Substance P and Tyrosine Hydroxylase Immunoreactivity in Substantia Nigra Ipsilateral to a Unilateral Lesion
  475. Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats
  476. Mechanism of modulation of [3H]raclopride binding to dopaminergic receptors in rat striatal membranes by sodium ions
  477. Possible involvement of G-proteins in the regulation of striatal dopamine D2 receptor affinity by cholecystokinin octapeptide
  478. Neurochemical Changes in the Hippocampus of the Brown Norway Rat During Aging
  479. Codistribution of the dopamine D3 receptor and glucocorticoid receptor mRNAs during striatal prenatal development in the rat
  480. Increased potency of neuropeptide y to antagonize α 2 -adrenoceptor function in the nucleus tractus solitarii of the spontaneously hypertensive rat
  481. NPY Y1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat
  482. Regional distribution of neural cell adhesion molecule immunoreactivity in the adult rat telencephalon and diencephalon. Partial colocalization with heparan sulfate proteoglycan immunoreactivity
  483. Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells
  484. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor
  485. Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal γ-aminobutyric acid transmission in the conscious rat
  486. Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents
  487. Centrally infused galanin-(1–15) but not galanin-(1–29) reduces the baroreceptor reflex sensitivity in the rat
  488. Dopaminergic transmission in the rat retina: evidence for volume transmission
  489. Evidence for receptors for hyaluronan in discrete nerve cell populations of the brain
  490. Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat
  491. Expression of cytochrome P45011B1 mRNA in the brain of normal and hypertensive transgenic rats
  492. Basic fibroblast growth factor expression and tenascin C immunoreactivity after partial unilateral hemitransection of the rat brain
  493. Ibotenic acid in the medial septum increased brain-derived neurotrophic factor mRNA levels in the dorsal rat hippocampal formation
  494. Evidence for a differential cholecystokinin-B and -A receptor regulation of gaba release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms
  495. Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain
  496. Localization of neuropeptide Y Y1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata
  497. Stimulation of adenosine A1 receptors prevents the EEG arousal due to dopamine D1 receptor activation in rabbits
  498. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism
  499. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat—I. Effects of perfusion with tetrodotoxin and low-calcium medium
  500. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat—II. Evidence for striataln-methyl-d-aspartate receptor regulation of striatonigral gabaergic transmission and motor function
  501. Kinetic evidence for isomerization of the dopamine receptor-raclopride complex
  502. Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites
  503. Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells contransfected with human CCKB and D2L receptor cDNAs
  504. The secretory trypsin inhibitor like-peptide, PEC-60 increases dopamine D2 receptor agonist induced inhibition of GABA release in the dorsolateral neostriatum of the awake freely moving rat. An in vivo microdialysis study
  505. Intercellular communication in the brain: Wiring versus volume transmission
  506. Additivity and non-additivity between dopamine-, norepinephrine-, carbachol- and GABA-stimulated GTPase activity
  507. Reduction of dopamine D2 receptor transduction by activation of adenosine A2a receptors in stablyA2a/D2 (long-form) receptor co-transfected mouse fibroblast cell lines: Studies on intracellular calcium levels
  508. A brief appraisal on some aspects of the receptor-receptor interaction
  509. 5-HT1A, GABAB, and pirenzepine-insensitive muscarinic receptors are functionally coupled to distinct pools of the same kind of G proteins in rat hippocampus
  510. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat
  511. Neurotensin-like immunoreactivity in odontoblasts and their processes in rat maxillary molar teeth and the effect of pulpotomy
  512. The concept of trophic units in the central nervous system
  513. Cholecystokinin octapeptide and the D2 antagonist raclopride induce Fos-like immunoreactivity in the shell part of the rat nucleus accumbens via different mechanisms
  514. Functional coupling of dopamine D2 and muscarinic cholinergic receptors to their respective G proteins assessed by agonist-induced activation of high-affinity GTPase activity in rat striatal membranes
  515. Increased vasopressor actions of intraventricular neuropeptide Y-(13–36) in spontaneously hypertensive versus normotensive Wistar-Kyoto rats. Possible relationship to increases in Y2 receptor binding in the nucleus tractus solitarius
  516. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study
  517. A single (−)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra
  518. Cholecystokinin OctapeptideIn VitroandEx VivoStrongly Modulates Striatal Dopamine D2Receptors in Rat Forebrain Sections
  519. Evidence for a differential modulation of the alpha-2 adrenoceptors by angiotensin II in the nucleus tractus solitarii of the spontaneously hypertensive and the Wistar-Kyoto normotensive rats
  520. Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats
  521. Receptor-Receptor Interactions and Their Relevance for Receptor Diversity
  522. On the cellular localization and distribution of carbonic anhydrase II immunoreactivity in the rat brain
  523. Differential brain area vulnerability to long-term subcortical excitotoxic lesions
  524. Presynaptic A2-adrenoceptors and neuropeptide Y Y2 receptors inhibit [3H]noradrenaline release from rat hypothalamic synaptosomes via different mechanisms
  525. 5-HT1A receptor-mediated activation of high-affinity GTPase in rat hippocampal membranes
  526. Bradykinin modulation of α2-Adrenoceptors in the nucleus tractus solitarii of the rat. An in vitro autoradiographical study
  527. Modafinil and cortical γ-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins
  528. The Brain Renin-Angiotensin System: Molecular Mechanisms of Cell to Cell Interactions
  529. Volume versus wiring transmission in the brain: A new theoretical frame for neuropsychopharmacology
  530. Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia
  531. Antagonistic regulation of α2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii
  532. On the plasticity of the cerebellar renin-angiotensin system: localization of components and effects of mechanical perturbation
  533. Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum
  534. A2a/D2 receptor interactions are not observed in COS-7 cells transiently transfected with dopamine D2 and adenosine A2a receptor cDNA
  535. Evidence for volume transmission in the dopamine denervated neostriatum of the rat after a unilateral nigral 6-OHDA microinjection. Studies with systemic d-amphetamine treatment
  536. Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system
  537. Evidence for an antagonitic angiotensin II/α2-adrenoceptor interaction in the nucleus tractus solitarii
  538. PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis study
  539. Chronic nicotine treatment counteracts dopamine D2 receptor upregulation induced by a partial meso-diencephalic hemitransection in the rat
  540. Selective modulation of the NPY receptors of the Y2 subtype by α2 receptors in the nucleus tractus solitarii of the rat. A cardiovascular and quantitative receptor autoradiographical analysis
  541. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons
  542. Basic fibroblast growth factor and steroid receptors in the aging hippocampus of the Brown Norway rat: Immunocytochemical analysis in combination with stereology
  543. Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes
  544. The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: Evidence for l-deprenyl-induced activation of reactive astrocytes
  545. The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors
  546. Facilitation of gaba release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens
  547. Intracisternally injected galanin-(1–15) modulates the cardiovascular responses of galanin-(1–29) and the 5-HT1A receptor agonist 8-OH-DPAT
  548. 6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig
  549. Coinjections of NPY(1–36) or [Leu31,Pro34]NPY with adrenaline in the nucleus tractus solitarius of the rat counteract the vasodepressor responses to adrenaline
  550. Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by acid
  551. Adrenalectomy alters discrete galanin mRNA levels in the hypothalamus and mesencephalon of the rat
  552. Adrenalectomy increases the number of substance P and somatostatin immunoreactive nerve cells in the rat lumbar dorsal root ganglia
  553. Cholecystokinin Receptor Subtypes Regulate Dopamine D2Receptors in Rat Neostriatal Membranes.
  554. Chronic continuous infusion of nicotine increases the disappearance of choline acetyltranferase immunoreactivity in the cholinergic cell bodies of the medial septal nucleus following a partial unilateral transection of the fimbria fornix
  555. Evidence for a regional distribution of hyaluronic acid in the rat brain using a highly specific hyaluronic acid recognizing protein
  556. Increase of basic fibroblast growth factor (bFGF, FGF-2) messenger RNA and protein following implantation of a microdialysis probe into rat hippocampus
  557. Subpopulations of primary sensory neurons show coexistence of neuropeptides and glucocorticoid receptors in the rat spinal and trigeminal ganglia
  558. On the regional distribution of heparan sulfate proteoglycan immunoreactivity in the rat brain
  559. Galanin-(1–15), but not galanin-(1–29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes
  560. Cholecystokinin-8 increases K+-evoked [3H]γ-aminobutyric acid release in slices from various brain areas
  561. Colocalization of Fos- and glucocorticoid receptor-immunoreactivities is present only in a very restricted population of dorsal horn neurons of the rat spinal cord after nociceptive stimulation
  562. Fast and widespread increase of basic fibroblast growth factor messenger RNA and protein in the forebrain after kainate-induced seizures
  563. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion
  564. Autoradiographic evidence for a bradykinin/angiotensin II receptor-receptor interaction in the rat brain
  565. Basic fibroblast growth factor (bFGF, FGF-2) immunoreactivity exists in the noradrenaline, adrenaline and 5-HT nerve cells of the rat brain
  566. Photochemically induced focal cerebral ischemia in rat: time dependent and global increase in expression of basic fibroblast growth factor mRNA
  567. Receptor-receptor interactions as an integrative mechanism in nerve cells
  568. Distribution of dopamine-immunoreactive neurons and their relationships to transmitter and hypothalamic hormone-immunoreactive neuronal systems in the rat mediobasal hypothalamus. A morphometric and microdensitometric analysis
  569. Microinjections of subpicomolar amounts of NPY(13–36) into the nucleus tractus solitarius of the rat counteract the vasodepressor responses of NPY(1–36) and of a NPY Y1 receptor agonist
  570. Evidence for a preventive action of the vigilance-promoting drug modafinil against striatal ischemic injury induced by endothelin-1 in the rat
  571. Indole-pyruvic acid treatment reduces damage in striatum but not in hippocampus after transient forebrain ischemia in the rat
  572. The renin-angiotensin system in the brain: an update 1993
  573. Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes
  574. Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression
  575. Neurochemical alterations but not nerve cell loss in aged rat neostriatum
  576. Regional expression of angiotensinogen mRNA in the brain of one-week-old, adult and old male rats
  577. Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system
  578. Persistent effects of subchronic toluene exposure on spatial learning and memory, dopamine-mediated locomotor activity and dopamine D2 agonist binding in the rat
  579. Subpicomolar amounts of NPY(13–36) injected into the nucleus tractus solitarius of the rat counteract the cardiovascular responses to l-glutamate
  580. The C-terminal neurotensin-(8–13) fragment potently modulates rat neostriatal dopamine D2 receptors
  581. Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes
  582. Cellular localization of angiotensin type 1 receptor and angiotensinogen mRNAs in the subfornical organ of the rat brain
  583. Induction of c-fos immunoreactivity in tyrosine hydroxylase and phenylethanolamine-N-methyltransferase immunoreactive neurons of the medulla oblongata of the rat after phosphate-buffered saline load in the urethane-anaesthetized rat
  584. Coexistence of c-Fos and glucocorticoid receptor immunoreactivities in the CRF immunoreactive neurons of the paraventricular hypothalamic nucleus of the rat after acute immobilization stress
  585. Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum
  586. Prenatal Development of Glucocorticoid Receptor Gene Expression and Immunoreactivity in the Rat Brain and Pituitary Gland: A Combined in situ Hybridization and Immunocytochemical Analysis
  587. Region-specific inhibition of potassium-evoked [3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13–36). Involvement of NPY receptors of the Y2 type
  588. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway
  589. Adenosine-dopamine interactions in the brain
  590. Brain Aging and Neuronal Plasticity
  591. Evidence for specific N-terminal galanin fragment binding sites in the rat brain
  592. Ganglioside GM1 counteracts the enhancing effects of subacute toluene exposure on apomorphine-induced locomotor activity
  593. Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum
  594. Colocalization of Fos- and Glucocorticoid Receptor-Like Immunoreactivities in the Rat Amygdaloid Complex After Immobilization Stress
  595. Intramembrane Interactions between Neurotensin Receptors and Dopamine D2Receptors as a Major Mechanism for the Neuroleptic-like Action of Neurotensin
  596. Steroidal regulation of coexisting neuronal messengers: Focus on double and triple immunolabeling procedures and on indirect evaluation of coexistence
  597. The distribution of angiotensin II AT1 receptor subtype mRNA in the rat brain
  598. Coactivation of dopamine D1 and D2 receptors increases the affinity of cholecystokinin-8 receptors in membranes from post-mortem human caudate-putamen
  599. Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y(13–36) in the awake unrestrained male rat
  600. Muscarinic modulation of acetylcholine release from slices of guinea pig nucleus basalis magnocellularis
  601. The semi-quantitative distribution and cellular localization of angiotensinogen mRNA in the rat brain
  602. Inhibitory effects of the psychoactive drug modafinil on ?-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig
  603. Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia
  604. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats
  605. The effects of neurotensin on GABA and acetylcholine release in the dorsal striatum of the rat: an in vivo mirodialysis study
  606. Colocalization of Peptide and Glucocorticoid Receptor Immunoreactivities in Rat Central Amygdaloid Nucleus
  607. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse
  608. Evidence for a protective action of the vigilance promoting drug Modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis
  609. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat
  610. Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat
  611. Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat
  612. Chronic continuous nicotine treatment causes decreased burst firing of nigral dopamine neurons in rats partially hemitransected at the meso-diencephalic junction
  613. Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion
  614. Stimulation of adenosine A2 receptors induces catalepsy
  615. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat
  616. Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transient cerebral ischemia in the rat
  617. Computer-assisted image analysis techniques allow a characterization of the compartments within the basal ganglia. Focus on functional compartments produced by d-amphetamine activation of the c-fos gene and its relationship to the glucocorticoid receptor
  618. Possible mechanisms underlying atypical neuroleptic drugs
  619. Prominent expression of acidic fibroblast growth factor in motor and sensory neurons
  620. A trypsin inhibitor-like peptide PEC-60 reduces the affinity of dopamine D2 agonist binding sites in rat neostriatal membranes
  621. Changes in striatal μ and δ opioid receptors after transient forebrain ischemia: a quantitative autoradiographic study
  622. Selective reduction of glucocorticoid receptor immunoreactivity in the hippocampal formation and central amygdaloid nucleus of the aged rat
  623. Subacute exposure to low concentrations of toluene affects dopamine-mediated locomotor activity in the rat
  624. Demonstration and nature of endothelin-3-like immunoreactivity in somatostatin and choline acetyltransferase-immunoreactive nerve cells of the neostriatum of the rat
  625. Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons
  626. Galanin increases potassium evoked release of [3H]5-hydroxytryptamine from rat hypothalamic synaptosomal preparations
  627. Ganglioside GM1 modulation of calcium/calmodulin-dependent protein kinase II activity and autophosphorylation
  628. Limited distribution of pertussis toxin in rat brain after injection into the lateral cerebral ventricles
  629. On the role of neuropeptide Y receptors of the Y2 type in the control of hypothalamic catecholaminergic mechanisms and neuroendocrine function. Central effects of the NPY fragment (13–36)
  630. Regional increases in ornithine decarboxylase mRNA levels in the rat brain after partial mesodiencephalic hemitransection as revealed by in situ hybridization histochemistry
  631. Evidence for a role of neosynthetized putrescine in the increase of glial fibrillary acidic protein immunoreactivity induced by a mechanical lesion in the rat brain
  632. Centrally injected neuropeptide Y (13–36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1–36) in the awake male rat
  633. Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis
  634. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence
  635. Vasopressor effects of intracerebroventricular injections of PEC-60, a novel porcine 60-residue intestinal peptide, in the awake unrestrained male rat
  636. Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors
  637. Acute and subchronic corticosterone treatment differentially modulates subcortical limbic and neostriatal nicotinic cholinergic receptors
  638. Effects of transient forebrain ischemia on peptidergic neurons and astroglial cells: evidence for recovery of peptide immunoreactivities in neocortex and striatum but not hippocampal formation
  639. Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization
  640. Distribution off pertussis toxin in the rat brain after injection into the lateral cerebral ventricles
  641. Evidence for the existence of angiotensin II like immunoreactivity in subpopulations of tyrosine hydroxylase immunoreactive neurons in the A1 and C1 area of the ventral medulla of the male rat
  642. Monoaminergic and Peptidergic Innervation of the Intermedio-Lateral Horn of the Spinal Cord. II. Relationship to preganglionic sympathetic neurons
  643. Monoaminergic and Peptidergic Innervation of the Intermedio-Lateral Horn of the Spinal Cord. I. Distribution patterns of nerve terminal networks
  644. Cellular and synaptic alterations in the aging brain
  645. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection
  646. Ganglioside GM1 prevents and reverses toluene-induced increases in membrane fluidity and calcium levels in rat brain synaptosomes
  647. Neurotensin reduces the affinity of dopamine D2 receptors in membranes from post mortem human caudate-putamen
  648. On the Role of Neuropeptide Y in Information Handling in the Central Nervous System in Normal and Physiopathological States.
  649. Aspects of neural plasticity in the central nervous system—I. Computer-assisted image analysis methods
  650. Aspects of neural plasticity in the central nervous system—II. Numerical classification in neuroanatomy
  651. Aspects of neural plasticity in the central nervous system—III. Methodological studies on the microdialysis technique
  652. Aspects of neural plasticity in the central nervous system—IV. Chemical anatomical studies on the aging brain
  653. Aspects of neural plasticity in the central nervous system—V. Studies on a model of transient forebrain ischemia in male Sprague-Dawley rats
  654. Aspects of neural plasticity in the central nervous system—VI. Studies of the effects of gangliosides on brain metabolic lesions
  655. Aspects of neural plasticity in the central nervous system—VII. Theoretical aspects of brain communication and computation☆
  656. Changes in pituitary-adrenal activity affect the binding properties of striatal dopamine D-2 receptors but not their modulation by neurotensin and cholecystokinin-8
  657. Evidence for thyrotropin-releasing hormone and glucocorticoid receptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat
  658. Morphometrical and microdensitometrical studies on peptide- and tyrosine hydroxylase-like immunoreactivities in the forebrain of rats prenatally exposed to methylazoxymethanol acetate
  659. Increased diffusion of prolactin-like material into the brain neuropil from homologous adenohypophyseal transplants in the rat neostriatum after a 6-OH-dopamine induced degeneration of the mesostriatal dopamine neurons
  660. Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and α2-adrenoceptors
  661. Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat
  662. Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus
  663. Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum
  664. Reduced inhibitory effects of clonidine and neuropeptide Y on3H-noradrenaline release from synaptosomes of the medulla oblongata of the spontaneously hypertensive rat
  665. Transient forebrain ischemia produces multiple deficits in dopamine D1 transmission in the lateral neostriatum of the rat
  666. Chronic nicotine treatment eliminates asymmetry in striatal glucose utilization following unilateral transection of the mesostriatal dopamine pathway in rats
  667. Pertussis toxin treatment counteracts the cardiovascular effects of neuropeptide Y and clonidine in the awake unrestrained rat
  668. Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat
  669. Reciprocal interactions between α2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat
  670. Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat
  671. Evidence for the existence of a population of arcuate neurons costoring choline acetyltransferase and tyrosine hydroxylase immunoreactivities in the male rat
  672. Neuropeptide Y increases the inhibitory effects of clonidine on potassium evoked3H-noradrenaline but not3H-5-hydroxytryptamine release from synaptosomes of the hypothalamus and the frontoparietal cortex of the male Sprague-Dawley rat
  673. Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol
  674. Evidence for nuclear ornithine decarboxylase activity in different brain regions of the male rat
  675. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications
  676. Persistent effects of neonatal toluene exposure on regional brain catecholamine levels and turnover in the adult male rat
  677. Toluene treatment in vitro and calcium-regulated protein phosphorylation in primary astroglial cell cultures from the rat striatum
  678. Morphometrical evidence for a complex organization of tyrosine hydroxylase-,enkephalin- and darpp-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum
  679. Effects of chronic toluene exposure of central monoamine and peptide receptors and their interactions in the adult male rat
  680. Survival of adenohypophyseal homologous transplants in the rat striatum associated with prolactin-like immunoreactivity in the surrounding neuropil of the striatum
  681. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain
  682. Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive nerve terminals and on glucocorticoid receptor-immunoreactive nerve cell nuclei in the paraventricular hypothalamic nucleus in ...
  683. Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive neurons in the rostral medulla oblongata of the adult and old male rat
  684. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
  685. Development of computer-assisted simulation procedure to analyze receptor modulatory processes
  686. Effects of toluene treatment in vivo and in vitro on the binding characteristics of [3H]neurotensin in rat striatal membranes
  687. Toluene induces changes in the morphology of astroglia and neurons in striatal primary cell cultures
  688. D1- and D2-receptor antagonist induce catalepsy via different efferent. Striatal pathways
  689. Effects of acute intermittent exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on neuroendocrine function in the diestrous rat
  690. Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex
  691. Neuropeptide y- and alpha-adrenergic receptors in pig spleen: Localization, binding characteristics, cyclic amp effects and functional responses in control and denervated animals
  692. D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release
  693. Effects of chronic uridine treatment on regional neuropeptide and tyrosine hydroxylase-like immunoreactivities in the brain of 12 month-old male rats
  694. Involvement of D1 dopamine receptors in the nicotine-induced noradrenaline release from hypothalamic and preoptic noradrenaline nerve terminal systems
  695. Pre- and Postsynaptic Features of the Central Angiotensin Systems. Indications for A Role of Angiotensin Peptides in Volume Transmission and for Interactions with Central Monoamine Neurons
  696. Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic amp-regulated phosphoprotein-32 immunoreactive neuronal structures and d1 receptor antagonist binding sites in various brain regions of the male rat—mismatches indicate a role of ...
  697. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade
  698. Ganglioside GM1 treatment prevents the effects of subacute exposure to toluene on binding characteristics in rat striatal membranes
  699. Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat
  700. Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric an...
  701. The characterization of the dopaminergic profile of EMD 23,448, an indolyl-3-butylamine: Selective actions on presynaptic and supersensitive postsynaptic DA receptor populations
  702. Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurons of the rat di- and telencephalon
  703. Effects of acute continuous exposure of the rat to cigarette smoke on amine levels and utilization in discrete hypothalamic catecholamine nerve terminal systems and on neuroendocrine function
  704. Evidence for the existence of ornithine decarboxylase-immunoreactive neurons in the rat brain
  705. Inhibitory effects of neuropeptide Y on cyclic AMP accumulation in slices of the nucleus tractus solitarius region of the rat
  706. Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex
  707. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines
  708. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat
  709. Intracisternal administration of cholecystokinin-8 counteracts the central cardiovascular effects of adrenaline and NPY. A study based on the coexistence of cholecystokinin, phenylethanolamine N-methyltransferase and neuropeptide Y immunoreactivity in ...
  710. Studies on the cellular localization and distribution of glucocorticoid receptor and estrogen receptor immunoreactivity in the central nervous system of the rat and their relationship to the monoaminergic and peptidergic neurons of the brain
  711. Nicotine-induced increases in brain luteinizing hormone releasing hormone-like immunoreactivity and in serum luteinizing hormone levels of the male rat
  712. Glucocorticoid mechanism of action: Monoclonal antibodies as experimental tools
  713. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  714. Increases in dopamine utilization in certain limbic dopamine terminal populations after a short period of intermittent exposure of male rats to cigarette smoke
  715. Neuropeptide Y enhances the inhibitory effects of clonidine on3H-noradrenaline release in synaptosomes isolated from the medulla oblongata of the male rat
  716. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: Selective protec...
  717. Chapter 15 Studies on peptide comodulator transmission. New perspective on the treatment of disorders of the central nervous system
  718. Chapter 19 Aspects on the information handling by the central nervous system: focus on cotransmission in the aged rat brain
  719. Chapter 20 Morphofunctional studies on the neuropeptide Y/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on receptor-receptor interactions in cotransmission
  720. Effects of acute and long-term treatment with neuroleptics on regional telencephalic neurotensin levels in the male rat
  721. Medianosomes as integrative units in the external layer of the median eminence. Studies on grf/catecholamine and somatostatin/catecholamine interactions in the hypothalamus of the male rat☆
  722. Preface
  723. Rapid important paper on the cellular localization and distribution of estrogen receptors in the rat tel- and diencephalon using monoclonal antibodies to human estrogen receptor
  724. Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function
  725. The effect of the ganglioside GM1 on neuronal plasticity
  726. Effects of neurotoxic and mechanical lesions of the mesostriatal dopamine pathway on striatal polyamine levels in the rat: Modulation by chronic ganglioside GM1 treatment
  727. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum
  728. Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor
  729. Central dopamine agonist activity on the 8-α-amino-ergoline CU 32-085
  730. Effects of Chronic Exposure to Cigarette Smoke on Amine Levels and Turnover in Various Hypothalamic Catecholamine Nerve Terminal Systems and on the Secretion of Pituitary Hormones in the Male Rat
  731. Distribution of neurophysin II immunoreactive nerve fibers within the subnuclei of the nucleus of the tractus solitarius of the rat
  732. The ergolene derivative MPME induces in the rat a behavioural syndrome associated with activation of dopamine D-1 receptors belonging to the dotted type of forebrain dopamine nerve terminals
  733. Evidence for the existence of putative dopamine-, adrenaline- and noradrenaline-containing vagal motor neurons in the brainstem of the rat
  734. Somatostatin-induced apnea: Interaction with hypoxia and hypercapnea in the rat
  735. Luteinizing hormone-releasing hormone increases dopamine turnover in the lateral palisade zone of the median eminence and reduces noradrenaline turnover in the nuc. Preopticus medialis of the hypophysectomized male rat
  736. Somatostatin produces apnea and is localized in medullary respiratory nuclei: a possible role in apneic syndromes
  737. l-glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes
  738. A method for rostrocaudal integration of morphometric information from transmitter-identified cell groups. A morphometrical identification and description of 5-HT cell groups in the medulla oblongata of the rat
  739. Central catecholamine neurons and exposure to dichloromethane. Selective changes in amine levels and turnover in tel- and diencephalic DA and NA nerve terminal systems and in the secretion of anterior pituitary hormones in the male rat
  740. New concepts on the structure of the neuronal networks: The miniaturization and hierarchical organization of the central nervous system*
  741. Evidence for a Modulation by Neuropeptide Y of the α-2 Adrenergic Transmission Line in Central Adrenaline Synapses. New Possibilities for Treatment of Hypertensive Disorders
  742. Studies on Neuropeptide-Y Catecholamine Interactions in Central Cardiovascular Regulation in the α-Chloralose Anaesthetized Rat. Evidence for a Possible New Way of Activating the α-2 Adrenergic Transmission Line
  743. Studies on neurotensin catecholamine interactions in the hypothalamus and in the forebrain of the male rat
  744. Transmitter and Peptide Systems in Areas Involved in the Control of Blood Pressure
  745. Evidence for the existence of a dopamine receptor of the D-1 type in the rat median eminence
  746. Morphometrical analysis of the distribution of luteinizing hormone-releasing hormone and tyrosine hydroxylase-immunoreactive nerve terminals within the lateral palisade zone of the median eminence of the male rat
  747. Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro
  748. Rat growth hormone and hypothalamic catecholamine nerve termianl systems. Evidence for rapid and discrete reductions in dopamine and noradrenaline levels and turnover in the median eminenece of the hypophysectomized male rat
  749. Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment
  750. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors
  751. Rapid and discrete changes in hypothalamic catecholamine nerve terminal systems induced by audiogenic stress, and their modulation by nicotine — Relationship to neuroendocrine function
  752. Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata
  753. Chronic antidepressant treatment and central 5-HT synapses
  754. Evidence for interactions between [3H]glutamate and [3H]kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity
  755. Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-hydroxytryptamine receptors in the brain of the rat
  756. Effects of chronic sino-aortic denervation in male rats on regional catecholamine levels and turnover and on neuroendocrine function
  757. Immunohistochemical indications of gastrin releasing peptide - bombesin-like immunoreactivity in the nervous system of the rat. Codistribution with substance P-like immunoreactive nerve terminal systems and coexistence with substance P-like immunoreact...
  758. Morphometric evaluation of the coexistence of renin-like and oxytocin-like immunoreactivity in nerve cells of the paraventricular hypothalamic nucleus of the rat
  759. A new approach to quantitate the density and antigen contents of high densities of transmitter-identified terminals. Immunocytochemical studies on different types of tyrosine hydroxylaxe immunoreactive nerve terminals in nucleus caudatus putamen of the...
  760. A morphometric analysis of transmitter identified dendrites and nerve terminals
  761. Morphometric characterization of transmitter-identified nerve cell groups: Analysis of mesencephalic 5-HT nerve cell bodies
  762. Principles for the morphological characterization of transmitter-identified nerve cell groups
  763. Toluene and telencephalic dopamine: Selective reduction of amine turnover in discrete da nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene
  764. Neuroanatomical methods for the quantitative evaluation of coexistence of transmitters in nerve cells. analysis of the ACTH- and β-endorphin immunoreactive nerve cell bodies of the mediobasal hypothalamus of the rat
  765. Interactions of nicotine and pentobarbitone in the regulation of telencephalic and hypothalamic catecholamine levels and turnover and of adenohypophyseal hormone secretion in the normal male rat
  766. Selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata and increase of hypothalamic adrenaline levels in the lyon strain of genetically hypertensive rats
  767. Vasopressor effects of substance P and C-terminal sequences after intracisternal injection to α-chloralose-anaesthetized rats: Blockade by a substance P antagonist
  768. On the interactive role of central noradrenaline neurons and corticosterone in two-way active avoidance acquisition in the rat
  769. Rat prolactin and hypothalamic catecholamine nerve terminal systems. Evidence for rapid and discrete increases in dopamine and noradrenaline turnover in the hypophysectomized male rat
  770. Muscarinic supersensitivity induced by septal lesion or chronic atropine treatment
  771. Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene*1
  772. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors
  773. Demonstration of central γ-aminobutyrate-containing nerve terminals by means of antibodies against glutamate decar☐ylase
  774. Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides
  775. Acute sino-aortic denervation in rats produces a selective increase of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata and a reduction of adrenaline levels in the anterior and posterior hypothalamus
  776. Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within the central nervous system of the mouse and rat
  777. Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection
  778. Renin-like immunocytochemical activity in the rat and mouse brain
  779. The mesolimbic dopamine system: Evidence for a high amine turnover and for a heterogeneity of the dopamine neuron population
  780. Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion
  781. Catecholamine-stimulated cyclic AMP formation in phenylethanolamine n-methyltransferase containing brain stem nuclei of normal rats and of rats with spontaneous genetic hypertension
  782. Compensatory bilateral changes in dopamine turnover after striatal kainate lesion
  783. A method to determine dopamine levels and turnover rate in discrete dopamine nerve terminal systems by quantitative use of dopamine fluorescence obtained by Falck-Hillarp methodology
  784. Catecholamine turnover changes in hypothalamus and dorsal midline area of the caudal medulla oblongata of spontaneously hypertensive rats
  785. Intrahippocampal injections of ibotenic acid provide histological evidence for a neurotoxic mechanism different from kainic acid
  786. Evidence for an exclusive localization of 3H-ADTN binding sites to postsynaptic nerve cells in the striatum of the rat
  787. Evidence for in vivo binding of apomorphine and bromocriptine to receptor sites not labelled by 3H-spiperone
  788. Hippocampal lesions indicate differences between the excitotoxic properties of acidic amino acids
  789. Ibotenic acid-induced neuronal degeneration: A morphological and neurochemical study
  790. Guanylate cyclase activity increases after kainic acid lesion of rat striatum
  791. The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine
  792. Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors
  793. Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs
  794. On the action of nicotine and cotinine on central 5-hydroxytryptamine neurons
  795. 3H-kainic acid binding: Relevance for evaluating the neurotoxicity of kainic acid
  796. On the role of ascending dopamine systems in the control of voluntary ethanol intake and ethanol intoxication
  797. Dopamine receptor agonists in brain research and as therapeutic agents
  798. Perforant path transections protect hippocampal granule cells from kainate lesion
  799. Further evidence that methergoline is a central 5-hydroxytryptamine receptor blocking agent
  800. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase
  801. Studies on dopamine turnover in ovariectomized or hypo-physectomized female rats. effects of 17β-estradiol benzoate, ethynodioldiacetate and ovine prolactin
  802. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors
  803. Cardiovascular effects of morphine and opioid peptides following intracisternal administration in chloralose-anesthetized rats
  804. 5-Hydroxytryptamine neurons and the sleep-wakefulness cycle. Effects of methergoline and zimelidine
  805. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine
  806. Interaction of Ergot Drugs with Central Monoamine Systems
  807. On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity
  808. Action on mitochondria and toxicity of metabolites of tri-n-butyltin derivatives
  809. Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine
  810. Enhancement of sexual behavior in the female rat by nicotine
  811. On the role of brain noradrenaline and the pituitary-adrenal axis in avoidance learning. I. Studies with corticosterone
  812. The effects of 5,7-dihydroxytryptamine-induced lesions of the ascending 5-hydroxytryptamine pathways on the sleep-wakefulness cycle
  813. Vasoactive intestinal polypeptide and the nervous system: Immunohistochemical evidence for localization in central and peripheral neurons, particularly intracortical neurons of the cerebral cortex
  814. Studies on GABA accumulation induced byγ-glutamyl-hydrazide in regions of rat brain following treatment with a tyrosine hydroxylase inhibitor and 6-hydroxy-dopamine
  815. Evidence for a nerve impulse-dependent GABA accumulation in the substantia nigra after treatment with γ-glutamylhydrazide
  816. On the catecholamine control of growth hormone regulation. Evidence for discrete changes in dopamine and noradrenaline turnover following growth hormone administration
  817. Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence
  818. Round table — Brain monoamines and behaviour the role of brain noradrenaline and the pituitary-adrenal axis in learning
  819. Dopamine and sexual behaviour in female rats. Effects of dopamine receptor agonists and sulpiride
  820. Serotonin and sexual behaviour in female rats. Effects of hallucinogenic indolealkylamines and phenylethylamines
  821. Dopamine in the nucleus accumbens: preferential increase of DA turnover by rat prolactin
  822. Central monoaminergic pathways with emphasis on their relation to the so called ‘extrapyramidal motor system’
  823. Evidence for an Inhibitory Dopaminergic and Stimulatory Noradrenergic Hypothalamic Influence of PMS-Induced Ovulation in the Immature Rat. I. Catecholamine Turnover Changes in Relation to the Critical Period
  824. Evidence for an Inhibitory Dopaminergic and Stimulatory Noradrenergic Hypothalamic Influence on PMS-Induced Ovulation in the Immature Rat. II. A Pharmacological Analysis
  825. Immunohistochemical evidence of vasoactive intestinal polypeptide-containing neurons and nerve fibers in sympathetic ganglia
  826. Involvement of central catecholamines in the feedback actions of 17β-estradiolbenzoate on luteinizing hormone secretion in the ovariectomized female rat
  827. Localization and characterization of phenylethanolamine N-methyl transferase in the brain of various mammalian species
  828. The Brain Isorenin-Angiotensin System: Localization and Biological Function
  829. Salivary IgA and serum IgG and IgA in recurrent aphthous stomatitis
  830. The effect of dl-, l- and d-Propranolol on central monoamine neurones
  831. The effect of dl-, l- and d-propranolol on central monoamine neurones
  832. Effect of some phosphodiesterase inhibitors on central dopamine mechanisms
  833. Further evidence that apomorphine increases GABA turnover in the DA cell body rich and DA nerve terminal rich areas of the brain
  834. Immunohistochemical evidence for the existence of angiotensin II-containing nerve terminals in the brain and spinal cord in the rat
  835. Behavioral effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways
  836. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: Studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal da pathway and quantitative recording of rotational behaviour
  837. Studies on the cholinergic and dopaminergic innervation of the neostriatum with the help of intraneostriatal injections of drugs
  838. The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity
  839. Interaction of ultrasound with neoplastic tissue
  840. Distribution of thyroptropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry
  841. The use of amine fluorescence histochemistry in the study of drugs, especially morphine, on the CNS
  842. Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors
  843. Thyrotropin releasing hormone (TRH)-containing nerve terminals in certain brain stem nuclei and in the spinal cord
  844. Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons
  845. Evidence for involvement of central NA neurones in alcohol intake. Increased alcohol consumption after degeneration of the NA pathway to the cortex cerebri
  846. Effect of ergot drugs on central 5-hydroxytryptamine neurons: Evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation
  847. The origin of the dopamine nerve terminals in limbic and frontal cortex. Evidence for meso-cortico dopamine neurons
  848. Inhibitory role of dopamine and 5-hydroxytryptamine in the sexual behaviour of female rats
  849. Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5,6-dihydroxytryptamine induced degeneration
  850. Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine
  851. Effects of Piperoxane on Sleep and Waking in the Rat. Evidence for Increased Waking by Blocking Inhibitory Adrenaline Receptors on the Locus Coeruleus
  852. Benzodiazepines and barbiturates: Turnover changes in central 5-hydroxytryptamine pathways
  853. Recent morphological and functional studies on hypothalamic dopaminergic and noradrenergic mechanisms
  854. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after dopa administration
  855. Hallucinogenic phenylethylamines: Interactions with serotonin turnover and receptors
  856. Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain
  857. Central catecholamine neurons, behavior and neuroleptic drugs: An analysis to understand the involvement of catecholamines in schizophrenia
  858. Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex
  859. Recent developments in monoamine histochemistry
  860. Mapping of central noradrenaline pathways with 6-Hydroxy-DOPA
  861. Serum and tissue dopamine-β-hydroxylase activity in hypophysectomized rats
  862. Evidence for Adrenaline Neurons in the Rat Brain
  863. Immunohistochemical studies on monoamine-containing cell systems
  864. Characterization, localization and regulation of dopamine-β-hydroxylase and of other catecholamine synthesizing enzymes
  865. Possible mechanism of the hypotensive action of 2,6-dichlorobenzylidene aminoguanidine: Evidence for central noradrenaline receptor stimulation
  866. Immunohistochemical localization of aromatic L-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine nerve cell bodies of the rat
  867. Effect of prostaglandin E2 on central and peripheral catecholamine neurons
  868. Action of m-tyrosine in experimental models: Evidence for possible antiparkinsonian activity
  869. Effects of intracerebral injections of 5,6-dihydroxytryptamine on central monoamine neurons: Evidence for selective degeneration of central 5-hydroxytryptamine neurons
  870. ET495 and brain catecholamine mechanisms: Evidence for stimulation of dopamine receptors
  871. Barbiturates and meprobamate: Decreases in catecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress
  872. Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats
  873. Immunohistochemical localization of three catecholamine synthesizing enzymes: aspects on methodology
  874. Further mapping out of central noradrenaline neuron systems: Projections of the ‘subcoeruleus’ area
  875. Interaction between cholinergic and catecholaminergic neurones in rat brain
  876. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons
  877. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decar☐ylase inhibition
  878. Mapping of central monoamine neurons in the monkey
  879. On the catecholamine innervation of the hypothalamus, with special reference to the median eminence
  880. Early and selective increase in brain dopamine levels after axotomy
  881. The effect of psychotomimetic glycolate esters on central monoamine neurons
  882. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's disease
  883. The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons
  884. Immunohistochemical studies on phenylethanolamine-N-methyltransferase, dopa-decarboxylase and dopamine-β-hydroxylase
  885. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons
  886. Minor tranquillizers, stress and central catecholamine neurons
  887. Central catecholamine turnover and self-stimulation behaviour
  888. On the projections from the locus coeruleus noradrenaline neurons: The cerebellar innervation
  889. Blockade of p-chloromethamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine
  890. Origin of 5-hydroxytryptophan and L-dopa accumulating in brain following decarboxylase inhibition
  891. Serotonin accumulation after monoamine oxidase inhibition
  892. Cellular Localization of Dopamine-β-hydroxylase and Phenylethanolamine-N-methyl Transferase as Revealed by Immunohistochemistry
  893. Pharmacological studies on the hypotensive effects of clonidine
  894. Depletion of catecholaminesin vivo induced by electrical stimulation of central monoamine pathways
  895. Studies on the action of some psychoactive drugs on central noradrenaline neurones after inhibition of dopamine-β-hydroxylase
  896. Studies on central and peripheral noradrenaline neurons using a new dopamine-β-hydroxylase inhibitor
  897. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
  898. Antiparkinsonian drugs and central dopamine neurons
  899. Evidence for a central noradrenaline receptor stimulation by clonidine
  900. Effects of antidepressant drugs of the imipramine type on central 5-hydroxytryptamine neurotransmission
  901. Central Monoamine Neurons and Pituitary—Adrenal Activity
  902. Morphological and Functional Aspects of Central Monoamine Neurons
  903. Cerebellar monoamine nerve terminals, a new type of afferent fibers to the cortex cerebelli
  904. Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro
  905. Castration, Sex Hormones, and Tubero-Infundibular Dopamine Neurons
  906. Factors involved in the Control of the Activity of the Tubero-Infundibular Dopamine Neurons during Pregnancy and Lactation
  907. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide
  908. Studies on uptake of intraventricularly administered tritiated noradrenaline and 5-hydroxytryptamine with combined fluorescence histochemical and autoradiographic techniques
  909. Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections
  910. The effect of imipramine on central monoamine neurons
  911. The effect of imipramine of central 5-hydroxytryptamine neurons
  912. Central Serotonin Neurons and Thermoregulation
  913. A Possible Role Played by Central Monoamine neurones in Thermo-Regulation
  914. Monoamine pathways to the cerebellum and cerebral cortex
  915. Evidence for dopamine receptor stimulation by apomorphine
  916. Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate
  917. Uptake and storage of catecholamines in rabbit brain after chronic reserpine treatment
  918. Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection
  919. A modification of the histochemical fluorescence method for the improved localization of 5-hydroxytryptamine
  920. Central catecholamine neurons and conditioned avoidance behaviour
  921. Noradrenaline nerve terminals in the hippocampal region of the rat and the guinea pig
  922. Some observations on the site of action of Oxypertin
  923. The effect of lithium on cerebral monoamine neurons
  924. Effect of large mesencephalic-diencephalic lesions on the noradrenalin, dopamine and 5-hydroxytryptamine neurons of the central nervous system
  925. The Effect of Haloperidol and Chlorpromazine on the Amine Levels of Central Monoamine Neurons
  926. A Quantitative Study on the Nigro-Neostriatal Dopamine Neuron System in the Rat
  927. Ascending Monoamine Neurons to the Telencephalon and Diencephalon
  928. Biochemical and Histochemical Studies on the Effects of Imipramine-like Drugs and (+)-Amphetamine on Central and Peripheral Catecholamine Neurons
  929. Responses of Skeletal Musculature and its Vasculature During “Diving” in the Duck: Peculiarities of the Adrenergic Vasoconstrictor Innervation
  930. Adrenergic Innervation of the Bronchial Muscle of the Cat
  931. Ascending noradrenaline neurons from the pons and the medulla oblongata
  932. Further Evidence for the Existence of Tubero-infundibular Dopamine Neurons
  933. Mechanoreceptors and adrenergic nerve terminals
  934. Absence of Monoamines in Olivo-Cochlear Fibres in Cat
  935. Evidence for the existence of an outflow of noradrenaline nerve fibres in the ventral roots of the rat spinal cord
  936. The Distribution of Adrenergic Nerve Fibres to the Blood Vessels in Skeletal Muscle
  937. Evidence for the existence of monoamine neurons in the central nervous system
  938. The Adrenergic Innervation of the Nasal Mucosa of Certain Mammals
  939. Ascending Systems of Catecholamine Neurons from the Lower Brain Stem
  940. Depletion of the Amine Stores in Brain Catecholamine Terminals on Amygdaloid Stimulation
  941. Effects of certain psychopharmaca on intraneuronal levels of 5-HT and catecholamines in the specific monoamine neurons of the rat brain
  942. Adrenergic Mechanisms in the Pupillary Light-Reflex Path
  943. Localization of monoamines in the lower brain stem
  944. Histochemical and Biochemical Observations on the Effect of Reserpine on Noradrenaline Storage in Vasoconstrictor Nerves
  945. A Method for the Demonstration of Monoamine-Containing Nerve Fibres in the Central Nervous System
  946. Mast cells and monoamines
  947. A method for the demonstration of adrenergic nerve fibres in peripheral nerves
  948. Cellular Localization of Monoamines in the Spinal Cord
  949. Observations on the cellular localization of dopamine in the caudate nucleus of the rat
  950. Chemical and Histochemical Evaluation of the Distribution of Catecholamines in the Rabbit and Guinea Pig Hearts
  951. Cellular Localization of Monoamines in the Median Eminence and in the Infundibular Stem of Some Mammals
  952. Cellular localization of monoamines in the median eminence and the infundibular stem of some mammals
  953. Freezing by Liquid Nitrogen, Cryostat Sectioning, and Vapor Fixation of Tissue Sections